Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Abroad (travel likely)RecruitingPHASE4

Conditions

Palmoplantar Pustulosis (PPP)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

First Hospital of China Medical University, Shenyang, China
Contact: Study coordinator (First Hospital of China Medical University) · guohao27@126.com · 024-83282524

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Palmoplantar Pustulosis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Coral Gables, United States

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Palmoplantar Pustulosis (PPP)

Abroad (travel likely)Recruiting

Xi'an, China